RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
China Chemical & Pharmaceutical Co Stock

China Chemical & Pharmaceutical Co EBIT 2025

China Chemical & Pharmaceutical Co EBIT

231.21 M TWD

Ticker

1701.TW

ISIN

TW0001701001

In 2025, China Chemical & Pharmaceutical Co's EBIT was 231.21 M TWD, a -39.03% increase from the 379.2 M TWD EBIT recorded in the previous year.

The China Chemical & Pharmaceutical Co EBIT history

YEAREBIT (undefined TWD)
2023231.21
2022379.2
2021423.89
2020421.23
2019374.64
2018336.44
2017277.3
2016286.44
2015245.96
2014278.78
2013235
2012261.2
2011281.8
2010295.5
2009290.2
2008276.3
2007304.7
2006289.2
2005325.9
2004216.7

China Chemical & Pharmaceutical Co Revenue, EBIT, Net Income

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details

Revenue, EBIT and Profit

ⓘ

Understanding Revenue, EBIT, and Income

Gain insights into China Chemical & Pharmaceutical Co, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by China Chemical & Pharmaceutical Co from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects China Chemical & Pharmaceutical Co’s net earnings, an ultimate measure of its financial health and profitability.

Yearly Analysis and Comparisons

Observe the yearly bars to understand the annual performance and growth of China Chemical & Pharmaceutical Co. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.

Utilizing Expectations for Investment

The expected values for the forthcoming years offer investors a glimpse into China Chemical & Pharmaceutical Co’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.

Investment Insights

Leveraging the comparison between Revenue and EBIT helps in assessing China Chemical & Pharmaceutical Co’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on China Chemical & Pharmaceutical Co’s growth potential.

China Chemical & Pharmaceutical Co Revenue, EBIT and net profit per share

DateChina Chemical & Pharmaceutical Co RevenueChina Chemical & Pharmaceutical Co EBITChina Chemical & Pharmaceutical Co Net Income
20238.57 B undefined231.21 M undefined322.29 M undefined
20228.46 B undefined379.2 M undefined477.54 M undefined
20217.95 B undefined423.89 M undefined517.51 M undefined
20208.18 B undefined421.23 M undefined557.37 M undefined
20197.97 B undefined374.64 M undefined384.69 M undefined
20187.58 B undefined336.44 M undefined369.87 M undefined
20176.24 B undefined277.3 M undefined310.74 M undefined
20165.78 B undefined286.44 M undefined313.21 M undefined
20155.63 B undefined245.96 M undefined353.7 M undefined
20145.3 B undefined278.78 M undefined347.72 M undefined
20135.17 B undefined235 M undefined240.3 M undefined
20124.95 B undefined261.2 M undefined322.1 M undefined
20115.02 B undefined281.8 M undefined305.9 M undefined
20104.56 B undefined295.5 M undefined358.4 M undefined
20094.35 B undefined290.2 M undefined387.9 M undefined
20083.89 B undefined276.3 M undefined63.2 M undefined
20073.95 B undefined304.7 M undefined225.2 M undefined
20063.61 B undefined289.2 M undefined243.3 M undefined
20053.5 B undefined325.9 M undefined46.4 M undefined
20043.32 B undefined216.7 M undefined778.9 M undefined

China Chemical & Pharmaceutical Co stock margins

The China Chemical & Pharmaceutical Co margin analysis displays the gross margin, EBIT margin, as well as the profit margin of China Chemical & Pharmaceutical Co. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for China Chemical & Pharmaceutical Co.

  • 3 years

  • 5 years

  • 10 years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details

Margin

ⓘ

Understanding Gross Margin

The gross margin, expressed as a percentage, delineates the gross profit made from the China Chemical & Pharmaceutical Co's sales revenue. A higher gross margin percentage indicates that the China Chemical & Pharmaceutical Co retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.

EBIT Margin Analysis

EBIT margin represents the China Chemical & Pharmaceutical Co's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.

Revenue Margin Insights

The revenue margin demonstrates the China Chemical & Pharmaceutical Co's total revenue generated. When comparing the revenue margin year over year, investors can gauge the China Chemical & Pharmaceutical Co's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.

Interpreting Expectations

The expected values for gross, EBIT, and revenue margins provide future financial outlook of the China Chemical & Pharmaceutical Co. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.

Comparative Analysis

Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the China Chemical & Pharmaceutical Co's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.

China Chemical & Pharmaceutical Co Margin History

China Chemical & Pharmaceutical Co Gross marginChina Chemical & Pharmaceutical Co Profit marginChina Chemical & Pharmaceutical Co EBIT marginChina Chemical & Pharmaceutical Co Profit margin
202336.62 %2.7 %3.76 %
202236.51 %4.48 %5.65 %
202136.04 %5.33 %6.51 %
202036.29 %5.15 %6.81 %
201937.35 %4.7 %4.83 %
201837.8 %4.44 %4.88 %
201730.79 %4.44 %4.98 %
201629.21 %4.95 %5.42 %
201528.65 %4.37 %6.28 %
201430.63 %5.26 %6.56 %
201330.28 %4.54 %4.64 %
201232.25 %5.28 %6.51 %
201131.93 %5.61 %6.09 %
201035.23 %6.49 %7.87 %
200934.3 %6.67 %8.91 %
200835.74 %7.1 %1.62 %
200734.23 %7.72 %5.7 %
200634.77 %8.02 %6.75 %
200537.86 %9.32 %1.33 %
200436.99 %6.52 %23.44 %

China Chemical & Pharmaceutical Co Aktienanalyse

What does China Chemical & Pharmaceutical Co do?

China Chemical & Pharmaceutical Co Ltd is a Chinese company specializing in the development, manufacturing, and sale of pharmaceutical products. The company was founded in 1955 and is headquartered in Taiyuan, the capital of Shanxi province. The business model of China Chemical & Pharmaceutical is focused on meeting the needs of customers in various areas such as healthcare, medicine, and public health. The company is a major player in the Chinese pharmaceutical industry and is engaged in research, development, and manufacturing of high-quality pharmaceutical products. China Chemical & Pharmaceutical offers a wide range of products, including antibiotics, antihypertensives, cancer therapy products, anti-ulcer medications, cardiovascular medications, and many other drugs marketed in China and overseas. In order to offer a more diverse range of products, the company has divided its divisions into various areas, including API (Active Pharmaceutical Ingredients), proprietary drugs, concentrated plant extracts, combination preparations, Western medicine, and traditional Chinese medicine. The company has been active in the market for many years and has established itself as a trusted and reliable partner in the Chinese pharmaceutical industry. China Chemical & Pharmaceutical products are available in many countries around the world, and the company has a strong presence in Asian countries such as India, Vietnam, and Malaysia. In recent years, the company has also invested in research and development of innovative new products. The company has an excellent research and development department specializing in the development of drugs for rare and neglected diseases. In addition to pure pharmaceutical production, the company also offers other services. The company is able to assist customers and partners in marketing products and can also provide consulting services in the field of pharmaceutical production. China Chemical & Pharmaceutical Co Ltd places great emphasis on quality and safety in drug manufacturing. Therefore, the company has implemented a quality management system that complies with international Good Manufacturing Practice (GMP) standards. This ensures that all products are of the highest quality and meet customer requirements. In summary, China Chemical & Pharmaceutical Co Ltd is an important and respected company in the Chinese pharmaceutical industry. The company has made many investments in recent years to expand and improve its range of products and services. The development of innovative new products and collaboration with customers and partners are central to its operations. Through its advanced production standards and high quality standards in drug manufacturing, the company has earned a good reputation in China and abroad. The China Chemical & Pharmaceutical Co Ltd is a Chinese company specializing in the development, manufacturing and sale of pharmaceutical products. It was founded in 1955 and is headquartered in Taiyuan, the capital of Shanxi province. The company's business model is focused on meeting the needs of customers in various areas such as healthcare, medicine, and public health. It is a major player in the Chinese pharmaceutical industry, engaged in research, development and manufacturing of high-quality pharmaceutical products. China Chemical & Pharmaceutical offers a wide range of products including antibiotics, antihypertensives, cancer therapy products, anti-ulcer medications, cardiovascular medications, and many other drugs marketed in China and overseas. To provide a more diverse range of products, the company has divided its divisions into various areas including API, proprietary drugs, concentrated plant extracts, combination preparations, Western medicine, and traditional Chinese medicine. The company has been operating in the market for many years and has established itself as a trusted and reliable partner in the Chinese pharmaceutical industry. Its products are available in many countries worldwide, with a strong presence in Asian countries such as India, Vietnam, and Malaysia. In recent years, the company has also invested in research and development of innovative new products, particularly for rare and neglected diseases. In addition to pharmaceutical production, the company also offers other services. It can assist customers and partners in product marketing, as well as provide consulting services in the field of pharmaceutical production. China Chemical & Pharmaceutical places great importance on quality and safety in drug manufacturing. It has implemented a quality management system that conforms to international GMP standards, ensuring that all products meet the highest quality standards and customer requirements. In summary, China Chemical & Pharmaceutical Co Ltd is an important and respected company in the Chinese pharmaceutical industry. It has made significant investments in expanding and improving its products and services, with a focus on developing innovative new products and collaborating with customers and partners. Its advanced production standards and commitment to quality have earned it a strong reputation in China and abroad. China Chemical & Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

EBIT Details

Analyzing China Chemical & Pharmaceutical Co's EBIT

China Chemical & Pharmaceutical Co's Earnings Before Interest and Taxes (EBIT) represents the company's operating profit. It is calculated by deducting all operating expenses, including the cost of goods sold (COGS) and operating expenses, from the total revenue, but before accounting for interest and taxes. It provides insights into the company’s operational profitability, excluding the impacts of financing and tax structures.

Year-to-Year Comparison

A yearly comparison of China Chemical & Pharmaceutical Co's EBIT can reveal trends in the company’s operational efficiency and profitability. An increase in EBIT over the years can indicate enhanced operational efficiency or growth in revenue, while a decrease might raise concerns about increased operating costs or declining sales.

Impact on Investments

China Chemical & Pharmaceutical Co's EBIT is a significant metric for investors. A positive EBIT suggests that the company is generating enough revenue to cover its operating expenses, an essential aspect for assessing the company’s financial health and stability. Investors closely monitor EBIT to gauge the company’s profitability and potential for future growth.

Interpreting EBIT Fluctuations

Fluctuations in China Chemical & Pharmaceutical Co’s EBIT can be due to variations in revenue, operating expenses, or both. An increasing EBIT indicates improved operational performance or increased sales, while a declining EBIT can signal rising operational costs or reduced revenue, prompting a need for strategic adjustments.

Frequently Asked Questions about China Chemical & Pharmaceutical Co stock

How much did China Chemical & Pharmaceutical Co achieve in EBIT for the current year?

In the current year, China Chemical & Pharmaceutical Co has achieved an EBIT of 231.21 M TWD.

What is EBIT?

EBIT stands for Earnings Before Interest and Taxes and refers to the profit before interest and taxes of a company China Chemical & Pharmaceutical Co.

How has the EBIT of China Chemical & Pharmaceutical Co developed in recent years?

The EBIT of China Chemical & Pharmaceutical Co has increased by -39.026% decreased compared to the previous year.

What does EBIT mean for investors?

EBIT provides investors with insights into a company's profitability as it reflects the profit before interest expenses and taxes.

Why is EBIT an important indicator for investors?

Since EBIT provides a more direct insight into a company's profit than net income, it is an important indicator for investors to assess the profitability of a company.

Why do EBIT values fluctuate?

EBIT values can fluctuate as they are influenced by various factors, such as revenue, costs, and tax effects.

What role does tax burden play in EBIT?

Tax burdens have a direct impact on a company's EBIT, as they are deducted from the profit.

How is EBIT presented in the balance sheet of the company China Chemical & Pharmaceutical Co?

The EBIT of China Chemical & Pharmaceutical Co is listed in the income statement.

Can EBIT be used as a single indicator for evaluating a company?

EBIT is an important indicator for evaluating a company, but additional financial ratios should also be considered to get a comprehensive picture.

Why is EBIT not equal to net profit?

The net profit of a company includes taxes and interest, while EBIT represents the profit before interest and taxes.

How much dividend does China Chemical & Pharmaceutical Co pay?

Over the past 12 months, China Chemical & Pharmaceutical Co paid a dividend of 0.8 TWD . This corresponds to a dividend yield of about 2.11 %. For the coming 12 months, China Chemical & Pharmaceutical Co is expected to pay a dividend of 0.8 TWD.

What is the dividend yield of China Chemical & Pharmaceutical Co?

The current dividend yield of China Chemical & Pharmaceutical Co is 2.11 %.

When does China Chemical & Pharmaceutical Co pay dividends?

China Chemical & Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of August, August, August, August.

How secure is the dividend of China Chemical & Pharmaceutical Co?

China Chemical & Pharmaceutical Co paid dividends every year for the past 20 years.

What is the dividend of China Chemical & Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0.8 TWD are expected. This corresponds to a dividend yield of 2.11 %.

In which sector is China Chemical & Pharmaceutical Co located?

China Chemical & Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von China Chemical & Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of China Chemical & Pharmaceutical Co from 8/20/2024 amounting to 0.5 TWD, you needed to have the stock in your portfolio before the ex-date on 7/26/2024.

When did China Chemical & Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 8/20/2024.

What was the dividend of China Chemical & Pharmaceutical Co in the year 2024?

In the year 2024, China Chemical & Pharmaceutical Co distributed 0.9 TWD as dividends.

In which currency does China Chemical & Pharmaceutical Co pay out the dividend?

The dividends of China Chemical & Pharmaceutical Co are distributed in TWD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von China Chemical & Pharmaceutical Co

Our stock analysis for China Chemical & Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of China Chemical & Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.